Adlai Nortye Stock (NASDAQ: ANL) stock price, news, charts, stock research, profile.
Open | $12.830 |
Close | - |
Volume / Avg. | 5.159K / 7.741K |
Day Range | 12.600 - 14.130 |
52 Wk Range | 7.111 - 19.300 |
Market Cap | $495.205M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 57 |
Short Interest | 0.02% |
Days to Cover | 5.45 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Adlai Nortye (NASDAQ: ANL) through any online brokerage.
Other companies in Adlai Nortye’s space includes: Cabaletta Bio (NASDAQ:CABA), KalVista Pharma (NASDAQ:KALV), Humacyte (NASDAQ:HUMA), Valneva (NASDAQ:VALN) and Celcuity (NASDAQ:CELC).
The latest price target for Adlai Nortye (NASDAQ: ANL) was reported by Cantor Fitzgerald on Tuesday, October 24, 2023. The analyst firm set a price target for 30.00 expecting ANL to rise to within 12 months (a possible 123.55% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Adlai Nortye (NASDAQ: ANL) is $13.4201 last updated April 24, 2024 at 9:18 AM EDT.
There are no upcoming dividends for Adlai Nortye.
Adlai Nortye’s Q3 earnings are confirmed for Tuesday, May 14, 2024.
There is no upcoming split for Adlai Nortye.
Adlai Nortye is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.